TY - JOUR
T1 - The tetraspanin CD53 regulates early B cell development by promoting IL-7R signaling
AU - Greenberg, Zev J.
AU - Monlish, Darlene A.
AU - Bartnett, Rachel L.
AU - Yang, Yihu
AU - Shen, Guomin
AU - Li, Weikai
AU - Bednarski, Jeffrey J.
AU - Schuettpelz, Laura G.
N1 - Publisher Copyright:
Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved.
PY - 2020
Y1 - 2020
N2 - The tetraspanin CD53 has been implicated in B cell development and function. CD53 is a transcriptional target of EBF1, a critical transcription factor for early B cell development. Further, human deficiency of CD53 results in recurrent infections and reduced serum Igs. Although prior studies have indicated a role for CD53 in regulating mature B cells, its role in early B cell development is not well understood. In this study, we show that CD53 expression, which is minimal on hematopoietic stem and progenitor cells, increases throughout bone marrow B cell maturation, and mice lacking CD53 have significantly decreased bone marrow, splenic, lymphatic, and peripheral B cells. Mixed bone marrow chimeras show that CD53 functions cell autonomously to promote B lymphopoiesis. Cd532/2 mice have reduced surface expression of IL-7Ra and diminished phosphatidylinositol 3 kinase and JAK/STAT signaling in prepro- and pro-B cells. Signaling through these pathways via IL-7R is essential for early B cell survival and transition from the pro-B to pre-B cell developmental stage. Indeed, we find increased apoptosis in developing B cells and an associated reduction in pre-B and immature B cell populations in the absence of CD53. Coimmunoprecipitation and proximity ligation studies demonstrate physical interaction between CD53 and IL-7R. Together, these data, to our knowledge, suggest a novel role for CD53 during IL-7 signaling to promote early B cell differentiation. The Journal of Immunology, 2020, 204: 58–67.
AB - The tetraspanin CD53 has been implicated in B cell development and function. CD53 is a transcriptional target of EBF1, a critical transcription factor for early B cell development. Further, human deficiency of CD53 results in recurrent infections and reduced serum Igs. Although prior studies have indicated a role for CD53 in regulating mature B cells, its role in early B cell development is not well understood. In this study, we show that CD53 expression, which is minimal on hematopoietic stem and progenitor cells, increases throughout bone marrow B cell maturation, and mice lacking CD53 have significantly decreased bone marrow, splenic, lymphatic, and peripheral B cells. Mixed bone marrow chimeras show that CD53 functions cell autonomously to promote B lymphopoiesis. Cd532/2 mice have reduced surface expression of IL-7Ra and diminished phosphatidylinositol 3 kinase and JAK/STAT signaling in prepro- and pro-B cells. Signaling through these pathways via IL-7R is essential for early B cell survival and transition from the pro-B to pre-B cell developmental stage. Indeed, we find increased apoptosis in developing B cells and an associated reduction in pre-B and immature B cell populations in the absence of CD53. Coimmunoprecipitation and proximity ligation studies demonstrate physical interaction between CD53 and IL-7R. Together, these data, to our knowledge, suggest a novel role for CD53 during IL-7 signaling to promote early B cell differentiation. The Journal of Immunology, 2020, 204: 58–67.
UR - http://www.scopus.com/inward/record.url?scp=85076876826&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1900539
DO - 10.4049/jimmunol.1900539
M3 - Article
C2 - 31748347
AN - SCOPUS:85076876826
SN - 0022-1767
VL - 204
SP - 58
EP - 67
JO - Journal of Immunology
JF - Journal of Immunology
IS - 1
ER -